Also trades as: HLOSF (OTC) · $vol 0M
4593.T JPX
Healios K.K.
1W: -1.0%
1M: +0.0%
3M: +13.4%
YTD: -25.1%
1Y: -54.4%
3Y: +2.5%
5Y: -84.2%
¥289.00 ($1.83)
+2.00 (+0.70%)
Weekly Expected Move ±7.1%
¥247
¥267
¥287
¥307
¥327
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$3.2B
-74.2% ▼
Capital Expenditures
$168M
-1020.0% ▼
5Y CAGR: -11.7%
Free Cash Flow
-$3.3B
-81.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$2M
+0.0% ▲
Net Change in Cash
$2.0B
+165.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4.5B | -$5.3B | -$3.8B | -$4.2B | -$2.2B |
| Depreciation & Amort. | $262M | $386M | $373M | $297M | $275M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$70M | $83M | $251M | $705M | -$64M |
| Other Non-Cash Items | -$819M | $260M | $377M | $1.4B | -$1.2B |
| Operating Cash Flow | -$5.1B | -$4.6B | -$2.8B | -$1.8B | -$3.2B |
| — Investing Activities — | |||||
| Capital Expenditures | -$300M | -$262M | -$25M | -$15M | -$168M |
| Acquisitions (Net) | $0 | $0 | $9M | $0 | $0 |
| Investment Purchases | -$433M | -$605M | -$1.2B | -$1.1B | -$960M |
| Investment Sales | $0 | $0 | $33M | $0 | $25M |
| Other Investing | -$3M | -$42M | $45M | -$293M | -$11M |
| Investing Cash Flow | -$736M | -$909M | -$1.1B | -$1.4B | -$1.1B |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$5.0B | -$2.5B | -$2.4B | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$2M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $229M | $281M | $2.8B | $328M | $1.3B |
| Financing Cash Flow | $7.0B | -$2.5B | $3.3B | $77M | $6.3B |
| Net Change in Cash | $1.2B | -$7.9B | -$525M | -$3.0B | $2.0B |
| Cash End of Period | $15.1B | $7.2B | $6.7B | $3.7B | $5.7B |
| Free Cash Flow | -$5.4B | -$4.9B | -$2.9B | -$1.8B | -$3.3B |